INNOVATIONS IN THE DIAGNOSIS AND TREATMENT OF TYPE 2 DIABETES MELLITUS

详细

The paper gives survey data pertinent to the epidemiology of type 2 diabetes mellitus (T2DM), its diagnosis and treatment. It discusses the new diagnostic criterion glycated hemoglobin (HbA1c). Individual target HbA1c values are estimated for different categories of patients. Current drug therapy for T2DM, including the use of innovative agents from the group of incretins, such as dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 agonists, is considered in detail.